阿克提斯肿瘤 AKTS
$15.82 +$0.97 (+6.53%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $15.82 0.00%
开盘$14.85
昨收$14.85
当日区间$14.82 – $16.10
成交量362.9K
市值$879.90M
市盈率（TTM）–
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例90.0%-0.28 个百分点，较上季度
持仓机构数149+7 ，较上季度
内部人近期交易7次买入 / 5次卖出净买入
空头持仓比例7.76% 占流通股回补天数 11.3 · 截至 15 Oct 2026
卖空成交量占比21.7%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：−$1.64M（8个净流入日，12个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有46.7%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从6.28%升至7.76%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Mirador Capital Partners, LP | Mutual Fund | 2026/Q3 | +93,434 | 0.2% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +41,719 | 0.1% |
| TCG Crossover Management, LLC | VC/PE Fund | 2026/Q3 | +696,560 | 1.3% |
| BlackRock | Mutual Fund | 2026/Q3 | +166,231 | 4.1% |
| Barclays PLC | Public Company | 2026/Q3 | +146,282 | 0.3% |
| Renaissance Technologies Corp. | Hedge Fund | 2026/Q3 | +95,400 | 0.2% |
| Polen Capital Management, LLC | Mutual Fund | 2026/Q3 | +63,514 | 0.1% |
| Tidal Investments LLC | Mutual Fund | 2026/Q3 | +57,059 | 0.1% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +55,757 | 0.9% |
| Raymond James Financial, Inc. | Public Company | 2026/Q3 | +50,464 | 0.1% |
| AQR Capital Management | Hedge Fund | 2026/Q3 | +47,504 | 0.1% |
| Quantinno Capital Management LP | Mutual Fund | 2026/Q3 | +46,887 | 0.1% |
| Great Lakes Advisors, LLC | Mutual Fund | 2026/Q3 | +43,612 | 0.1% |
| Mirador Capital Partners, LP | Mutual Fund | 2026/Q3 | +40,124 | 0.1% |
| Merrill Lynch, Pierce, Fenner & Smith Incorporated | Private Company | 2026/Q3 | +39,308 | 0.1% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 22 Sep 2026 | Akos Czibere | Chief Medical Officer | Derivative Exercise and Sale | -12,500 | $21.03 | – |
| 19 Jul 2026 | Ken Herrmann | Chair of Scientific Advisory Board & Independent Director | Derivative Exercise and Sale | -4,856 | $24.56 | – |
| 16 Jul 2026 | Ken Herrmann | Chair of Scientific Advisory Board & Independent Director | Derivative Exercise and Sale | -3,065 | $25.21 | – |
| 7 Jul 2026 | Shulamit Ron-Bigger | Chief Operating Officer | Derivative Exercise and Sale | -50,000 | $28.75 | – |
| 7 Jul 2026 | Akos Czibere | Chief Medical Officer | Derivative Exercise and Sale | -50,000 | $28.71 | – |
| 11 Jan 2026 | MPM BioImpact LLC | Private Acquisition | +1,112,777 | $18.00 | 10,260,064 | |
| 11 Jan 2026 | MPM BioImpact LLC | Derivative Exercise and Retained | +8,208,187 | – | 10,260,064 | |
| 11 Jan 2026 | Eli Lilly and Company | Initial Statement of Beneficial | +0 | – | 6,344,114 | |
| 11 Jan 2026 | Lloyd Segal | Independent Director | Derivative Exercise and Retained | +19,631 | – | 19,631 |
| 11 Jan 2026 | EcoR1 Capital, LLC | Private Acquisition | +2,222,222 | $18.00 | 4,824,469 | |
| 11 Jan 2026 | EcoR1 Capital, LLC | Derivative Exercise and Retained | +2,602,247 | – | 4,824,469 | |
| 11 Jan 2026 | Vida Ventures Advisors, LLC | Private Acquisition | +835,000 | $18.00 | 5,829,212 | |
| 11 Jan 2026 | Vida Ventures Advisors, LLC | Derivative Exercise and Retained | +4,994,212 | – | 5,829,212 | |
| 7 Jan 2026 | MPM BioImpact LLC | Initial Statement of Beneficial | +0 | – | 597,393 | |
| 7 Jan 2026 | Todd Foley | Chairperson | Initial Statement of Beneficial | +0 | – | 37,866 |
| 7 Jan 2026 | Helen Kim | Former Independent Director | Initial Statement of Beneficial | +0 | – | 37,866 |
| 7 Jan 2026 | Michael Sherman | Independent Director | Initial Statement of Beneficial | +0 | – | 93,846 |
| 7 Jan 2026 | Lloyd Segal | Independent Director | Initial Statement of Beneficial | +0 | – | 6,489 |
| 7 Jan 2026 | Mary Thistle | Independent Director | Initial Statement of Beneficial | +0 | – | 93,846 |
| 7 Jan 2026 | Matthew Roden | Chief Executive Officer | Initial Statement of Beneficial | +0 | – | 2,149,409 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 4,313,744 | 7.8% | 11.3 |
| 30 Sep 2026 | 4,715,294 | 8.5% | 7.3 |
| 15 Sep 2026 | 3,252,475 | 5.8% | 11.5 |
| 31 Aug 2026 | 3,175,040 | 5.7% | 10.4 |
| 14 Aug 2026 | 3,447,126 | 6.2% | 15.0 |
| 31 Jul 2026 | 3,470,122 | 6.3% | 12.8 |
暂无评论——快来第一个聊聊 AKTS。